As you may recall, Lobbying for Pharmacy Profits was one of my top four trends for the pharmacy supply and payment system in 2007.
Looks like the AMP Final Rule will keep this trend going. On Tuesday, Reps. Nancy Boyda (D-Kan.) and Jo Ann Emerson (R-Mo.) will introduce The Patient Access to Medicaid Generic Prescription Drugs Act of 2007. They will also participate in a conference call with the National Community Pharmacists Association (NCPA), which appears to be doing a good job of refocusing Average Manufacturer Price (AMP) into a debate over “access” versus the relative profits of generics.
Here are the details in case you want to tune in:
WHEN: Tuesday, July 24, 2007, at 2:00 p.m. EST
(UPDATE: Time changed to 11:00 PM per new press release.)
CALL-IN #: 800-944-8766 (Conference Code: 39108)
You can also read the full press release from NCPA. Drug Topics has a summary of the proposed legislation, which will focus on generic dispensing targets. I'll weigh in after I read the bill.